Newsroom

LONDON--(BUSINESS WIRE)--Leeds office demand shifts south of the river to the East Quarter, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. While the traditional City Core remained Leeds’s dominant office location, its share of headline leasing activity fell from a five-year average of around 80% to 60% in 2025. “A growing number of professional and financial services firms have been drawn to the Eas...

PARIS--(BUSINESS WIRE)--Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen jou...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 10/04/2026 FR0013230612 2 12...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as trustee of the Schroders Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. Fo...

德州伍德蘭茲--(BUSINESS WIRE)--(美國商業資訊)-- Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH)今天公布了截至2026年1月31日的第四季和2025會計年度的財務業績。 總裁兼執行長Saleh Sagr表示：「在截至2026年1月31日的三個月內，公司淨銷售額為5510萬美元，較上年同期的4500萬美元成長1010萬美元，增幅達22.4%。成長主要歸功於中東和北美地區銷售量的提升。毛利為1730萬美元，較去年的1520萬美元成長210萬美元，反映出業務活動的增加。銷售、一般和行政費用從970萬美元微增至1030萬美元，主要原因是薪資成本上升，而獎金成本下降部分抵銷了該影響。公司的有效稅率(ETR)為12.3%，上年同期為32.1%，反映了不同稅務管轄區產品結構的影響。受上述因素推動，歸屬於普通股的淨收入為490萬美元，較2024會計年度第四季的180萬美元成長310萬美元，增幅達172.2%。」 Sagr先生評論道：「在截至2026年1月31日的年度內，公司淨銷售額為2.109億美元，較上年同期的1.5...

LONDON--(BUSINESS WIRE)--European companies adapting mainframe systems are moving from experimental to operational use of GenAI within standardized workflows, ISG says....

DUBLIN--(BUSINESS WIRE)--  Date: April 15th, 2026 Not for the distribution, directly or indirectly into the United States or any jurisdiction in which such distribution would be unlawful. Issuer: Republic of Italy --- Pre-Stabilisation Notice IMI - Intesa Sanpaolo (contact: IMI-Intesa Sanpaolo Syndicate Desk; telephone +39 02 7261 6502) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regu...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 16.04.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 10,572,193.52 23.494  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 16.04.2026 GMAY.LN IE000P0FL8E3 900,002.00 USD 35,343,310.77 39.270  ...

CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus infections are a major cause of complications in transplant patients, with no approved treatments. The company is pioneering an oral therapy that addresses the full spectrum of BK infection, from early reactivation thr...